Delivery Order SPE2DB20D3101-SPE2DB22FQUG7
- Not listed
- This federal contract award, valued at $5,844.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,247,768 units of Glucagon 1 mg Emergency Kits, a critical medical product used in the treatment of severe hypoglycemia. The contract has an ultimate completion date of January 8, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen...
- This federal contract award, valued at $3,662.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GLUCAGON 1 MG EMERGENCY KITS, a critical medical product used in the treatment of low blood sugar emergencies. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,598.20, is for the delivery of 4566926475 GLUCAGON 1 MG EMERGENCY KITS. The contract is a Firm Fixed Price Delivery Order with a completion date of January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA,...
- This federal contract award, valued at $3,899.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,193,922 units of Glucagon 1 mg Emergency Kits, with a performance period ending on May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,319.60, is for the delivery of 4,567,756,504 Glucagon 1 mg Emergency Kits. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a large for-profit...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,619,529 GLUCAGON 1 MG EMERGENCY KITS, with a ceiling value of $1,084.90. The award is a firm fixed-price contract with a completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,677.13 Firm Fixed Price Delivery Order is for the supply of 4556201254 GLUCAGON 1 MG EMERGENCY KITS to support military healthcare programs. The award has an Ultimate Completion Date of February 9, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,860.08 firm fixed-price delivery order is for the supply of 4556496558 GLUCAGON 1 MG EMERGENCY KITS. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the...
- This federal contract award, valued at $3,365.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,328,050 units of Glucagon 1 mg Emergency Kits, with a performance period ending on June 26, 2023. This is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,461.66, is for the delivery of 4563801112 Glucagon 1 mg Emergency Kits. The contract has a completion date of February 29, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a critical supplier of...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FQUG7Delivery Order
This federal contract award, valued at $1,548.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLUCAGON 1 MG EMERGENCY KITS. The contract has an ultimate completion date of September 12, 2022 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) that specializes in distributing a wide variety of pharmaceutical and medical products to federal agencies, with a focus on the DLA and Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/9/22 |